Liquid chromatography–mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase
Authors:
- 1 September 2008
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 872 (1-2) , 141-147
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- A Novel Poly(ADP-ribose) Polymerase Inhibitor, ABT-888, Sensitizes Malignant Human Cell Lines to Ionizing Radiation Under Oxia and HypoxiaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsClinical Cancer Research, 2007
- PARP inhibitors for cancer therapyExpert Reviews in Molecular Medicine, 2005
- BIOANALYTICAL LIQUID CHROMATOGRAPHIC METHOD VALIDATION. A REVIEW OF CURRENT PRACTICES AND PROCEDURESJournal of Liquid Chromatography & Related Technologies, 2000